Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2011
Efficacy and safety of an in-the-mouth bone conduction device for single-sided deafness.
Контролируемое клиническое исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Murray Michael, Popelka Gerald R, Miller Ross
Аннотация
OBJECTIVE: To determine the efficacy, benefit, and safety of a new in-the-mouth bone conduction device (SoundBite Hearing System) for single-sided deafness (SSD).
STUDY DESIGN: A multicenter, controlled, nonrandomized prospective unblinded study of SSD patients wearing the device.
SETTINGS: Ambulatory care centers typical of those where SSD patients are diagnosed and treated.
PATIENTS: Adults (ages >18 and <80 yr) with acquired, permanent SSD (N=28) and no current use of any SSD device.
INTERVENTION: Continual daily wear of the new device over a 30-day trial period.
MAIN OUTCOME MEASURES: The Hearing in Noise Test (HINT), the Abbreviated Profile of Hearing Aid Benefit (APHAB), comprehensive pretrial and posttrial medical, audiologic, and dental examinations and an SSD questionnaire.
RESULTS: The Hearing in Noise Test scores improved an average of -2.5 dB after 30 days, compared with wearing no device (p<0.001). The Abbreviated Profile of Hearing Aid Benefit scores improved (p<0.05) for all subjects for the Global and Background Noise subscales and for all but 1 subject for the Reverberation and Ease of Communication subscales. There were no medical, audiologic, or dental complications.
CONCLUSION: The SoundBite system is safe and effective and provides substantial benefit for SSD patients with continual daily use over a 30-day period.
STUDY DESIGN: A multicenter, controlled, nonrandomized prospective unblinded study of SSD patients wearing the device.
SETTINGS: Ambulatory care centers typical of those where SSD patients are diagnosed and treated.
PATIENTS: Adults (ages >18 and <80 yr) with acquired, permanent SSD (N=28) and no current use of any SSD device.
INTERVENTION: Continual daily wear of the new device over a 30-day trial period.
MAIN OUTCOME MEASURES: The Hearing in Noise Test (HINT), the Abbreviated Profile of Hearing Aid Benefit (APHAB), comprehensive pretrial and posttrial medical, audiologic, and dental examinations and an SSD questionnaire.
RESULTS: The Hearing in Noise Test scores improved an average of -2.5 dB after 30 days, compared with wearing no device (p<0.001). The Abbreviated Profile of Hearing Aid Benefit scores improved (p<0.05) for all subjects for the Global and Background Noise subscales and for all but 1 subject for the Reverberation and Ease of Communication subscales. There were no medical, audiologic, or dental complications.
CONCLUSION: The SoundBite system is safe and effective and provides substantial benefit for SSD patients with continual daily use over a 30-day period.